Feedback

Dr. Akash Chaurasiya 

Assistant Professor
Department of Pharmacy

Development of nano-particulate based carrier system for anticancer therapeutics delivery, Development of vesicular carrier system for enhancing drug efficacy and safety, Oral Bioavailability enhancement using novel approaches, Lyophilization Technique, Differentiated Product Development (505b2 based approaches), Cancer therapeutics, 505b2, Liposomes, Lipid Emulsion, LIpid Crystal, Formulation Development, Nanoparticles
Birla Institute of Technology & Science, Pilani
Hyderabad Campus
Jawahar Nagar, Kapra Mandal
Dist.-Medchal-500 078
Telangana, India

Publications

After joining BITS Pilani (TPRL)

 
  1. Kanan Panchal, Akhila Reddy, Rishi Paliwal, Akash Chaurasiya, "Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product"Drug Delivery and Translational Research, in press (Scopus indexed; Impact Factor: 5.4).
  2. Akash Chaurasiya, Sonali Singh, Kanan Panchal, Rishi Paliwal, Akanksha Malviya “ Fundamentals of targeted drug delivery system”.Molecular pharmaceutics and nano drug delivery: Fundamentals and Challenges, Elsevier. pp 289-309.https://doi.org/10.1016/B978-0-323-91924-1.00007-1 
  3. Rani, Sarita, Sahoo Rakesh Kumar, Mahale Ashutosh,  Panchal Kanan, Chaurasiya Akash, Kulkarni Onkar, Kuche Kaushik, Jain Sanyog, Nakhate Kartik Ajazuddin, Gupta Umesh, "Sialic Acid Engineered Prodrug Nanoparticles for Co-delivery of Bortezomib and Selenium in Tumor Bearing Mice"  Bioconjugate Chemistry Manuscript ID: bc-2023-00210n.R3                                                                                                                                                                                                                                                                                                                          
  4. Ekta Pardhi, Rati Yadav, Akash Chaurasiya, Jitender Madan, Santosh Kumar Guru, Shashi Bala Singh, Neelesh Kumar Mehra, "Multifunctional targetable liposomal drug delivery system in the management of leukemia: Potential, opportunities, and emerging strategies", Life Sciences 325, 2023, 21771- Published online: 13 May 2023. (Impact Factor: 6.78). https://doi.org/10.1016/j.lfs.2023.1217                                                                                                                                                                                                                                                    
  5. Tanisha Gupta, Rakesh Kumar Sahoo, Himani Singh, Sumeet Katke, Akash Chaurasiya, Umesh Gupta, "Lipid Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities", AAPS PharmSciTech 24, 102, 2023 - Published online:11 April 2023. (Impact Factor: 4.026).   https://link.springer.com/article/10.1208/s12249-023-02555-2                                                                                                                                                                                                                                                               
  6. Rachna M. Kumar, Hitesh Kumar, Tanvi Bhatt, Rupshee Jain, Kanan Panchal, Akash Chaurasiya, Vikas Jain, “Fisetin in Breast Cancer: Attributes, Developmental Aspects and Nanotherapeutics”, Pharmaceuticals, 16, 196, 2023 - Published online: 28 Jan 2023. (Impact Factor: 5.215). https://doi.org/10.3390/ph16020196
     
  7. Sarita  Rani,  Rakesh Kumar Sahoo, Vinay Kumar, Akash Chaurasiya, Onkar Kulkarni, Ashutosh Mahale, Sumeet Katke, Kaushik Kuche, Vivek Yadav, Sanyog Jain, Kartik Nakhate, Ajazuddin, Umesh Gupta, “N-2-hydroxypropylmethacrylamide–polycaprolactone polymeric micelles in co-delivery of proteasome inhibitor and polyphenol: Exploration of synergism or antagonism”, Molecular Pharmaceutics, 20, 524-544, 2023 - Published online: 28 Oct 2022. (Impact Factor: 5.364).
    https://doi.org/10.1021/acs.molpharmaceut.2c00752

  8. Kanan Panchal, Sumeet Katke, Sanat Kumar Dash, Ankit Gaur, Aishwarya Shinde, Nithun Saha, Neelesh Kumar Mehra, Akash Chaurasiya*, “An expanding horizon of complex injectable products: Development and regulatory considerations”, Drug Delivery & Translational Research, 13, 433-472, 2023 - Published online: 14 Aug 2022. (Scopus indexed; Impact Factor: 5.671). (*Corresponding author).
    https://doi.org/10.1007/s13346-022-01223-5

  9. Sakshi Priya, Unnati Batra, Samshritha RN, Sudhanshu Sharma, Akash Chaurasiya, Gautam Singhvi, “Polysaccharide-based nanofibers for pharmaceutical and biomedical applications: A review”,  International Journal of Biological Macromolecules, 218, 209-224, 2022 - Published online: 21 Jul 2022. (Scopus indexed; Impact Factor: 8.025). 
    https://doi.org/10.1016/j.ijbiomac.2022.07.118

  10. Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya*, “Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview”, International Immunopharmacology, 95, 107508, 2021 - Published online: 13 Mar 2021. (Scopus indexed; Impact Factor: 5.714). (*Corresponding author)
    https://doi.org/10.1016/j.intimp.2021.107508

  11. Akash Chaurasiya*, Amruta Gorajiya, Kanan Panchal, Sumeet Katke & Ajeet Kumar Singh, “A review on multivesicular liposomes for pharmaceutical applications: Preparation, characterization and translational challenges”, Drug Delivery & Translational Research, 12, 1569-1587, 2022 - Published online: 01 Oct 2021. (Scopus indexed; Impact Factor: 5.671). (*Corresponding author)
    https://doi.org/10.1007/s13346-021-01060-y

  12. Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal, Akash Chaurasiya*, “Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspective”, Therapies, 77, 425-443, 2022 - Published online: 02 Nov 2021. (Scopus indexed; Impact Factor: 3.367). (*Corresponding author) 
    https://doi.org/10.1016/j.therap.2021.10.010 

  13. Rishi Paliwal, Pramod Kumar, Akash Chaurasiya, Rameshroo Kenwat, Sumeet Katke, Shivani Rai Paliwal, “Development of nanomedicines and nanosimilars: Recent advances in regulatory landscape”, Current Pharmaceutical Design, 28, 165-177, 2022 - Published online: 09 Dec 2021. (Scopus indexed; Impact Factor: 3.310). 
    https://doi.org/10.2174/1381612827666211115170001

  14. Akash Chaurasiya*, Parameswar Patra, Chiranjeev Singh and Manika Chourasiya, "Potential of nanotechnology based approaches for HIV/AIDS treatment", ISSRF Newletter, Indian Society for the Study of Reproduction and Fertility, 26, 63-66 (2020). (*Corresponding author)

      
    Before joining BITS Pilani (TPRL)
     
  15. A K Singh, A Chaurasiya, M H Warsi, M Chaurasiya, G K Jain, D Asati, R K Khar, & R Mukherjee, Oral pharmacokinetic study of exemestane SMEDDS and suspension in rat plasma by Liquid Chromatography-Mass Spectrometric analysis, J liq chrom and rel tech, 2012, 35, 2162-2174.

  16. C Maheshwari, R S Pandey, A Chaurasiya, A Kumar, D T Selvam, G B K S Prasad, & V K Dixit, Non-ionic surfactant vesicles mediated transcutaneous immunization against Hepatitis B, International Immunopharmacology, 2011, 11, 1516-1522.

  17. M H Warsi, A Chaurasiya, G K Jain, S Pathan, P Chander, A K Singh, S Talegaonkar, F J Ahmad, and R K Khar, Aqueous Humor Pharmacokinetics of Dorzolamide Loaded PLGAChitosan Nanoparticles by Ultra Performance Liquid Chromatography, Cur Pharm Anal, 2011, 7, 189-194.

  18. A Chaurasiya, A K Singh, S C Upadhyay, D Asati, F J Ahmad, R Mukherjee, & R K Khar, Lipidic nanocarrier for oral bioavailability enhancement of an anticancer agent: Formulation design & evaluation, Adv Sci Lett, 2012, 11, 43-52.

  19. A K Singh, A Chaurasiya, G K Jain, A Awasthi, D Asati, G Mishra, R K Khar & R Mukherjee, High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats, Talanta, 2009, 78,  1310–1314. 

  20. A K Singh, A Chaurasiya, A Awasthi, G Mishra, D Asati, R K Khar & R Mukherjee, Oral Bioavailability Enhancement of Exemestane from Self-Microemulsifying Drug Delivery System (SMEDDS)AAPS PharmSciTech. 2009, 10, 906-16.

  21. S K Jain, A Chaurasiya, Y Gupta, A Jain, P Dagur, B Joshi, & V M Katoch, Development and Characterization of 5-FU bearing Ferritin appended Solid Lipid Nanoparticles for Tumor Targeting, J of Micro, 2008, 25, 289-97.

  22. A K Singh, A Chaurasiya, M Singh, S C Upadhyay, R Mukherjee & R K Khar, Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): Development and Optimization, AAPS PharmaSciTech, 2008,  9, 628-34.